- Home
- SCYX vs ANGH Comparison
SCYX vs ANGH Comparison
Compare SCYX & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- ANGH
- Stock Information
- Founded
- SCYX 1999
- ANGH 2012
- Country
- SCYX United States
- ANGH United Arab Emirates
- Employees
- SCYX N/A
- ANGH N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- ANGH Telecommunications Equipment
- Sector
- SCYX Health Care
- ANGH Consumer Discretionary
- Exchange
- SCYX Nasdaq
- ANGH Nasdaq
- Market Cap
- SCYX 28.5M
- ANGH 32.1M
- IPO Year
- SCYX 2014
- ANGH N/A
- Fundamental
- Price
- SCYX $0.70
- ANGH $0.50
- Analyst Decision
- SCYX
- ANGH
- Analyst Count
- SCYX 0
- ANGH 0
- Target Price
- SCYX N/A
- ANGH N/A
- AVG Volume (30 Days)
- SCYX 127.6K
- ANGH 10.8K
- Earning Date
- SCYX 08-07-2025
- ANGH 07-15-2025
- Dividend Yield
- SCYX N/A
- ANGH N/A
- EPS Growth
- SCYX N/A
- ANGH N/A
- EPS
- SCYX N/A
- ANGH N/A
- Revenue
- SCYX $2,630,000.00
- ANGH $78,093,405.00
- Revenue This Year
- SCYX $463.61
- ANGH N/A
- Revenue Next Year
- SCYX $310.80
- ANGH N/A
- P/E Ratio
- SCYX N/A
- ANGH N/A
- Revenue Growth
- SCYX N/A
- ANGH 88.72
- 52 Week Low
- SCYX $0.66
- ANGH $0.42
- 52 Week High
- SCYX $2.29
- ANGH $1.08
- Technical
- Relative Strength Index (RSI)
- SCYX 40.46
- ANGH 41.97
- Support Level
- SCYX $0.70
- ANGH $0.47
- Resistance Level
- SCYX $0.75
- ANGH $0.50
- Average True Range (ATR)
- SCYX 0.04
- ANGH 0.02
- MACD
- SCYX 0.00
- ANGH 0.00
- Stochastic Oscillator
- SCYX 32.29
- ANGH 14.29
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.